In:
Pharmaceutical Technology in Hospital Pharmacy, Walter de Gruyter GmbH, Vol. 3, No. 3 ( 2018-08-28), p. 177-182
Abstract:
Intrathecal analgesia has increased over the last 30 years. In oncology, it is a real alternative for the treatment of refractory pain. The diversity of the molecules alone or in combination that can be used, the risk related to the route of administration, and the cost of certain molecules are all arguments in favor of centralized preparation within the pharmacy. The purposes of this work are first of all to explain the reasons for centralization of these preparations, and in a second time to describe the circuit developed within our establishment.
Type of Medium:
Online Resource
ISSN:
2365-242X
,
2365-2411
DOI:
10.1515/pthp-2018-0017
Language:
English
Publisher:
Walter de Gruyter GmbH
Publication Date:
2018
detail.hit.zdb_id:
2861908-0
Bookmarklink